• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

    531.43 +4.32 (+0.82%)
    Streaming Delayed Price Updated: 12:23 PM EDT, Apr 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Madrigal Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    News headline image
    Why Madrigal Pharmaceuticals Stock Gained 20% This Week ↗
    Two key tailwinds fueled a surge in the biotech's share price this week. 
    Via The Motley Fool
    News headline image
    Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names ↗
    Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is... 
    Via Benzinga
    News headline image
    Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout ↗
    Shares are closing in on a buy point after retaking their 50-day moving average. 
    Via Investor's Business Daily
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
    Via Investor Brand Network
    News headline image
    5 Best Stocks to Buy in April ↗
    These powerful trends should yield stellar returns for investors in April and beyond. 
    Via The Motley Fool
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning Trading
    Via Investor Brand Network
    News headline image
    2 Surging Healthcare Stocks That Are Still Worth Buying ↗
    These two NASH drugmakers have a lot of room to run. 
    Via The Motley Fool
    Here's How Much You Would Have Made Owning Madrigal Pharmaceuticals Stock In The Last 5 Years ↗
     
    Via Benzinga
    News headline image
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,800 Today ↗
     
    Via Benzinga
    News headline image
    Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run ↗
    Viking Therapeutics stock might in the midst of a historic run. 
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics a Smart Buy on the Dip? ↗
    The stock recently fell around 25% for reasons that had nothing to do with its lead program. 
    Via The Motley Fool
    News headline image
    Want Diversified Upside in Biotechnology? Check out LABU
    Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. 
    Via MarketBeat
    Topics ETFs Stocks
    News headline image
    The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
    To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
    Via InvestorPlace
    News headline image
    Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle ↗
    Meanwhile, the company is facing a stout rival in the form of Madrigal Pharmaceuticals. 
    Via Investor's Business Daily
    News headline image
    1 Incredible Growth Stock That Could Turn $200,000 Into $1 Million by 2030 ↗
    This clinical-stage biopharma stock could harbor one of the best-selling drugs of all time. 
    Via The Motley Fool
    News headline image
    3 Incredible Growth Stocks to Buy if the Market Dips ↗
    These top growth stocks sport premium valuations for a very good reason. 
    Via The Motley Fool
    News headline image
    3 Top Healthcare Stocks to Buy for January ↗
    These healthcare stocks have a lot going for them in the new year. 
    Via The Motley Fool
    News headline image
    CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗
    Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
    Via Investor's Business Daily
    News headline image
    5 Most Expensive Health Care Stocks You Should Worry About ↗
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    News headline image
    Why These 7 Healthcare Stocks Could Soar in 2023 ↗
    These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
    Via InvestorPlace
    News headline image
    5 Top Stocks for January ↗
    Now is the time to begin crafting your watch list for 2023. 
    Via The Motley Fool
    News headline image
    Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week ↗
    Potential short squeeze plays gained steam in 2021 and have continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common... 
    Via Benzinga
    News headline image
    This Stock That Tripled in 2022 Could Rocket Even Higher in 2023 ↗
    Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results. 
    Via The Motley Fool
    News headline image
    Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗
    The market uptrend is under pressure. 
    Via Investor's Business Daily
    News headline image
    Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector ↗
    The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    News headline image
    Why Madrigal Pharmaceuticals Was a Top Stock This Week ↗
    Biotech bulls stampeded the company following its latest clinical update. 
    Via The Motley Fool
    News headline image
    7 Drug Stocks That Will Soar in 2023 ↗
    These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
    Via InvestorPlace
    News headline image
    Earnings Optimism Puts Wind In Wall Street's Sails ↗
    The major indexes are extending their rally off a mid-December losing streak. 
    Via Talk Markets
    News headline image
    Why Did Viking Therapeutics Stock Skyrocket
    VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. 
    Via MarketBeat
    News headline image
    Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.